New Insights Into the Biology and Advances in the Management of Multiple Myeloma
| Author | : Jean Luc Harousseau |
| Publisher | : |
| Total Pages | : 267 |
| Release | : 2007 |
| Genre | : Multiple myeloma |
| ISBN | : |
New Insights Into The Biology And Advances In The Management Of Multiple Myeloma
Download New Insights Into The Biology And Advances In The Management Of Multiple Myeloma full books in PDF, epub, and Kindle. Read online free New Insights Into The Biology And Advances In The Management Of Multiple Myeloma ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Advances in Biology and Therapy of Multiple Myeloma
| Author | : Nikhil C. Munshi |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 291 |
| Release | : 2012-12-09 |
| Genre | : Medical |
| ISBN | : 1461452600 |
Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. Two major advances are making this goal possible. First, recent advances in genomics and proteomics in MM have allowed for increased understanding of disease pathogenesis, identified novel therapeutic targets, allowed for molecular classification, and provided the scientific rationale for combining targeted therapies to increase tumor cell cytotoxicity and abrogate drug resistance. Second, there is now an increased understanding of how adhesion of MM cells in bone marrow (BM) further impacts gene expression in MM cells, as well as in BM stromal cells (BMSCs). As a result of these advances in oncogenomics on the one hand and increased understanding of the role of the BM in the pathogenesis of MM on the other, a new treatment paradigm targeting the tumor cell and its BM microenvironment to overcome drug resistance and improve patient outcome has now been developed. Thalidomide, lenalidomide, and Bortezomib are three agents which target the tumor cell in its microenvironment in both laboratory and animal models and which have rapidly translated from the bench to the bedside. Ongoing efforts are using oncogenomics and cell signaling studies to identify next generation of therapies in MM on the one hand, and to inform the design of combination trials on the other. This new paradigm for overcoming drug resistance and improving patient outcome in MM has great promise not only to change the natural history of MM, but also to serve as a model for targeted therapeutics directed to improve outcome of patients with MM.
Advances in Biology and Therapy of Multiple Myeloma
| Author | : Nikhil C. Munshi |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 322 |
| Release | : 2012-11-15 |
| Genre | : Medical |
| ISBN | : 146144666X |
Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. Two major advances are making this goal possible. First, recent advances in genomics and proteomics in MM have allowed for increased understanding of disease pathogenesis, identified novel therapeutic targets, allowed for molecular classification, and provided the scientific rationale for combining targeted therapies to increase tumor cell cytotoxicity and abrogate drug resistance. Second, there is now an increased understanding of how adhesion of MM cells in bone marrow (BM) further impacts gene expression in MM cells, as well as in BM stromal cells (BMSCs). As a result of these advances in oncogenomics on the one hand and increased understanding of the role of the BM in the pathogenesis of MM on the other, a new treatment paradigm targeting the tumor cell and its BM microenvironment to overcome drug resistance and improve patient outcome has now been developed. Thalidomide, lenalidomide, and Bortezomib are three agents which target the tumor cell in its microenvironment in both laboratory and animal models and which have rapidly translated from the bench to the bedside. Ongoing efforts are using oncogenomics and cell signaling studies to identify next generation of therapies in MM on the one hand, and to inform the design of combination trials on the other. This new paradigm for overcoming drug resistance and improving patient outcome in MM has great promise not only to change the natural history of MM, but also to serve as a model for targeted therapeutics directed to improve outcome of patients with MM.
Biology and Management of Multiple Myeloma
| Author | : James R. Berenson |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 375 |
| Release | : 2004-05-14 |
| Genre | : Medical |
| ISBN | : 159259817X |
Expert physicians and clinical researchers summarize and explain all the recent advances in the biology and treatment of bone marrow-based malignancy. On the biological side, the authors show the characteristics of the malignant cell and describe the significant roles played by oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus, and cytokines. New epidemiological findings and prognostic factors are also analyzed. On the clinical side, the authors provide a comprehensive review of conventional treatment regimens, as well as a discussion of newer experimental approaches involving immunologic targeting, inhibitors of drug resistance, and antitumor agents.
Multiple Myeloma Cancer
| Author | : Ethan D. |
| Publisher | : Shuttle Systems |
| Total Pages | : 233 |
| Release | : 2024-03-11 |
| Genre | : Health & Fitness |
| ISBN | : 1776846567 |
"Multiple Myeloma Cancer: A Comprehensive Resource for Patients and Families" is an essential guide for anyone touched by multiple myeloma. This book offers a thorough understanding of this complex cancer, from its biology to the latest in treatments and research advancements, providing invaluable support for patients and their loved ones.Deep Dive into Multiple MyelomaStart your journey with an in-depth look at multiple myeloma, including its types, epidemiology, and the historical perspective on research. Gain crucial insights into the nature of plasma cells and the genetic and molecular factors that contribute to the development of this cancer.Understanding Risk Factors and Early DetectionLearn about the risk factors associated with multiple myeloma and the importance of early detection. This book covers screening methods and the significance of early diagnosis in improving treatment outcomes.Symptoms, Diagnosis, and StagingRecognize the symptoms of multiple myeloma and understand the diagnostic process, including tests and procedures. Grasp the staging system, its role in disease progression, and its impact on treatment and prognosis.Exploring Treatment OptionsNavigate the treatment landscape of multiple myeloma, from conventional chemotherapy and stem cell transplantation to cutting-edge targeted therapies and immunotherapies. This book provides comprehensive information to help make informed decisions about care and treatment.Managing Side Effects and ComplicationsUnderstand and manage the side effects and complications of treatment, including the impact on bone health and strategies for infection management.Nutrition and LifestyleDiscover the importance of nutrition and lifestyle changes in supporting overall health during and after treatment. Get practical advice on diet, exercise, and lifestyle adjustments.Psychological and Emotional SupportFind guidance on coping with the emotional and psychological impacts of multiple myeloma. Learn about the importance of support systems, counseling, and the role of community and support groups.Living with Multiple MyelomaAddress the day-to-day challenges of living with multiple myeloma, including chronic management, quality of life issues, and survivorship care.Advances in ResearchStay informed about the latest in multiple myeloma research and emerging treatments. This section highlights the importance of clinical trials and future possibilities in myeloma care.Special ConsiderationsGain insights into how multiple myeloma affects different populations, including considerations for younger and elderly patients, and the unique aspects of the disease in men and women.Advocacy and Community EngagementUnderstand the role of patient advocacy, find community resources, and learn how to engage in raising awareness about multiple myeloma.The Future of Myeloma CareLook ahead to the innovations and evolving landscape of myeloma therapy, offering hope and a vision for the future of myeloma care."Multiple Myeloma Cancer: A Comprehensive Resource for Patients and Families" is more than just a book; it's a companion and guide through the journey of multiple myeloma. It provides the knowledge, support, and resources needed to navigate this challenging path with confidence and hope.
Multiple Myeloma
| Author | : Shaji Kumar, MD |
| Publisher | : Demos Medical Publishing |
| Total Pages | : 240 |
| Release | : 2010-08-24 |
| Genre | : Medical |
| ISBN | : 1935281453 |
Multiple Myeloma: The second issue of Emerging Cancer Therapeutics focuses on multiple myelomas also known as plasma cell myeloma, KahlerÌs Disease and myelomatosis. It is estimated that over 20,000 new cases are diagnosed each year with over 10,000 people dying from these malignancies. Multiple myelomas are highly treatable but rarely curable. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management. Management options and outcomes for individuals with multiple myelomas improved dramatically with the introduction of chemotherapy. Even further improvements in prognosis have occurred because of the introduction of newer therapies such as pulse corticosteroids, thalidomide, bortezomib, and autologous and allogeneic stem cell transplantation. With the increased number of therapeutic options to choose from, the clinician is better placed to offer effective therapy but at the same time is challenged to keep abreast of the rapidly changing treatment landscape and the newly emerging data that is shaping the treatment options today and in the future. Multiple Myeloma provides a comprehensive and in-depth review of this group of malignancies. This volume reviews the current literature, provides critical evaluations of the data and offers evidence-based recommendations. About the Series: Emerging Cancer Therapeutics is an invited review publication providing a through analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging. Features of Emerging Cancer Therapeutics include: Editorial board of nationally recognized experts across the spectrum of Cancer Therapeutics In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics Issues edited by an authority in specific subject area Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience Emphasizes multidisciplinary approaches to research and practice
Genetic and Molecular Epidemiology of Multiple Myeloma
| Author | : Suzanne Lentzsch |
| Publisher | : Springer Science & Business Media |
| Total Pages | : 132 |
| Release | : 2013-01-09 |
| Genre | : Medical |
| ISBN | : 1461446600 |
Multiple myeloma is a plasma cell malignancy characterized by complex heterogenous cytogenetic abnormalities that accounts for 1.4% of all cancers, and approximately 10% of hematologic malignancies. The clinical manifestations of multiple myeloma include lytic bone lesions, cytopenia, hypercalcemia, renal dysfunction, hyperviscosity of the blood, immunodeficiency, and peripheral neuropathy. Based on the clinical and genetic data, probably all cases of multiple myeloma arise from an asymptomatic monoclonal gammopathy of unknown significance. The exact mechanism of the transition from MGUS to overt multiple myeloma is still not well understood. Recent oncogenomic studies have further advanced our understanding of the molecular pathogenesis of multiple myeloma. This book will give a comprehensive overview of the genetic and molecular epidemiology of multiple myeloma in order to get a more refined and conclusive understanding of this disease.
Multiple Myeloma Cancer
| Author | : Ethan D. Anderson |
| Publisher | : |
| Total Pages | : 0 |
| Release | : 2024-01-29 |
| Genre | : Health & Fitness |
| ISBN | : |
"Multiple Myeloma Cancer: A Comprehensive Resource for Patients and Families" is an essential guide for anyone touched by multiple myeloma. This book offers a thorough understanding of this complex cancer, from its biology to the latest in treatments and research advancements, providing invaluable support for patients and their loved ones. Deep Dive into Multiple Myeloma Start your journey with an in-depth look at multiple myeloma, including its types, epidemiology, and the historical perspective on research. Gain crucial insights into the nature of plasma cells and the genetic and molecular factors that contribute to the development of this cancer. Understanding Risk Factors and Early Detection Learn about the risk factors associated with multiple myeloma and the importance of early detection. This book covers screening methods and the significance of early diagnosis in improving treatment outcomes. Symptoms, Diagnosis, and Staging Recognize the symptoms of multiple myeloma and understand the diagnostic process, including tests and procedures. Grasp the staging system, its role in disease progression, and its impact on treatment and prognosis. Exploring Treatment Options Navigate the treatment landscape of multiple myeloma, from conventional chemotherapy and stem cell transplantation to cutting-edge targeted therapies and immunotherapies. This book provides comprehensive information to help make informed decisions about care and treatment. Managing Side Effects and Complications Understand and manage the side effects and complications of treatment, including the impact on bone health and strategies for infection management. Nutrition and Lifestyle Discover the importance of nutrition and lifestyle changes in supporting overall health during and after treatment. Get practical advice on diet, exercise, and lifestyle adjustments. Psychological and Emotional Support Find guidance on coping with the emotional and psychological impacts of multiple myeloma. Learn about the importance of support systems, counseling, and the role of community and support groups. Living with Multiple Myeloma Address the day-to-day challenges of living with multiple myeloma, including chronic management, quality of life issues, and survivorship care. Advances in Research Stay informed about the latest in multiple myeloma research and emerging treatments. This section highlights the importance of clinical trials and future possibilities in myeloma care. Special Considerations Gain insights into how multiple myeloma affects different populations, including considerations for younger and elderly patients, and the unique aspects of the disease in men and women. Advocacy and Community Engagement Understand the role of patient advocacy, find community resources, and learn how to engage in raising awareness about multiple myeloma. The Future of Myeloma Care Look ahead to the innovations and evolving landscape of myeloma therapy, offering hope and a vision for the future of myeloma care. "Multiple Myeloma Cancer: A Comprehensive Resource for Patients and Families" is more than just a book; it's a companion and guide through the journey of multiple myeloma. It provides the knowledge, support, and resources needed to navigate this challenging path with confidence and hope.
Multiple Myeloma: New Insights for the Healthcare Professional: 2013 Edition
| Author | : |
| Publisher | : ScholarlyEditions |
| Total Pages | : 290 |
| Release | : 2013-07-22 |
| Genre | : Medical |
| ISBN | : 1481654276 |
Multiple Myeloma: New Insights for the Healthcare Professional: 2013 Edition is a ScholarlyEditions™ book that delivers timely, authoritative, and comprehensive information about Diagnosis and Screening. The editors have built Multiple Myeloma: New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Diagnosis and Screening in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Multiple Myeloma: New Insights for the Healthcare Professional: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
